Cratering VC funding for biotech: Still plenty bad, although not what it originally seemed
Are venture capitalists really shunning biotechnology, as I wrote a few days ago? A deeper look at the data suggests the answer is still yes, although not exactly for the reasons I first suspected.
First off, the most striking data point I noted in my earlier… Continue Reading
Biotech’s dirty little secret: VCs are heading for the hills — fast
(UPDATED: See below.)
At first glance, life-sciences investments seemed largely to hold steady in the third quarter, despite failing to match a 7.6 percent rise in overall funding, according to data from VentureOne and Ernst & Young. A closer look, however, reveals a very different story —… Continue Reading
The credit crunch: A capital bypass for life sciences?
Over at VentureBeat proper, Matt highlights a theory advanced by venture capitalist Keith Benjamin, who argues that the credit crunch now threatening the private-equity boom may have the unexpected effect of boosting returns in technology investments. (Keith puts this all down in his own words… Continue Reading
Galen Partners closes $250M healthcare fund
Galen Partners, a Stamford, Conn., private-equity firm that concentrates solely on the healthcare industry, closed a $250 million fund, its fifth. The fund will focus on healthcare IT, medical devices and specialty pharmaceuticals.
The private equity bubble
Forget the Web 2.0 bubble, which is in the process of bursting.
Start worrying about the private equity bubble instead.
Our capitalist system has a habit of swinging between fear and greed (see Stu Phillips’ column today), and right now we’re seeing it lean toward greed •… Continue Reading
Dan Primack launches PEHub, a private equity blog and forum
Dan Primack, the guy who holds court at PE Week each morning and rants about the world of private equity, is launching a blog site Monday. It is called PEHub.
He’ll be blogging, there will be columns from buyout and VC guys, and other ways for… Continue Reading
Unprecedented amount of money searching for home
U.S. private equity firms have raised a record $177.89 billion, according to Dow Jones VentureOne.
Private equity firms have an unprecedented amount of cash sitting in their treasure chests. Since they are typically mandated to invest it within a certain time frame, this signals that… Continue Reading